- Easy Tracking In The Watchlist
Is Humacyte, Inc. stock still a buy after falling -15.36% on Wednesday?
(Updated on Jun 03, 2026)
The Humacyte, Inc. stock price fell by -15.36% on the last day (Wednesday, 3rd Jun 2026) from $0.0550 to $0.0466. During the last trading day the stock fluctuated 0.110% from a day low at $0.0465 to a day high of $0.0466. The price has fallen in 5 of the last 10 days and is down by -25.76% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 2 thousand shares were bought and sold for approximately $85.33 .
The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.0484) are considered to be a "second chance" to get out. According to the fan-theory -$0.0153 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
HUMAW Signals & Forecast
There are few to no technical positive signals at the moment. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0628 and $0.0785. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -33.40%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Humacyte, Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.000051 between high and low, or 0.110%. For the last week the stock has had daily average volatility of 111.44%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HUMAW) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Humacyte, Inc. to open at $0.0466, and during the day (based on 14 day Average True Range), to move between $0 and $0.0954, which gives a possible trading interval of +/-$0.0977 (+/-95 412.24%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 95 412.24% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.
With no support below and resistance from accumulated volume @ $0.0503, some $0.0038 (8.06%) from the current price of $0.0466, our system finds the risk reward not very attractive.
Is Humacyte, Inc. stock A Buy?
Humacyte, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-8.625
Strong Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $0.0466 ( 0.0351%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
HUMAW Performance
Trading levels for HUMAW
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0466 | 0.145% |
| R2 | 0.0466 | 0.103% |
| R1 | 0.0466 | 0.0769% |
| Price | 0.0466 | |
| S1 | 0.0465 | -0.0068% |
| S2 | 0.0465 | -0.0326% |
| S3 | 0.0465 | -0.0745% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.0567 | 21.80% |
| R2 | 0.0550 | 18.15% |
| R1 | 0.0503 | 8.06% |
| Price | 0.0466 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Humacyte, Inc. Stock.
Buy HUMAW